Previous 10 | Next 10 |
Generex Biotechnology ( OTCQB:GNBT ) declares 1:1 common stock dividend. More news on: Generex Biotechnology Corporation, Dividend News, Healthcare stocks news, , Read more ...
MIRAMAR, Fla., June 20, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) is pleased to announce that the company today declared the previously announced 1:1 common stock dividend. The Record Date...
Management to Provide Update on Initiatives & Strategic Plans Call-in Details MIRAMAR, Fla., June 17, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced the following access inf...
MIRAMAR, Fla., June 07, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ), in response to the large volume of investor calls, today provided an update on its new 1:1 dividend that has been approved by t...
H.C. WAINWRIGHT 21 st ANNUAL GLOBAL INVESTMENT CONFERENCE The Lotte New York Palace Hotel, New York, NY September 8 – 10, 2019 MIRAMAR, Fla., June 04, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (OTCQB:GNBT) is pleased to announce that Joe Moscato, the company...
Generex shareholder dividend follow-up Launch of FDA Cleared Excellagen® for Wound Management by subsidiary Olaregen Therapeutix Update on NuGenerex Immuno-Oncology Spin-out and dividend shares Pending completion of acquisitions: ° Pantheon Medical and MediSource Partner...
MIRAMAR, Fla., May 31, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) is pleased to announce that the company plans to declare a 1:1 stock dividend, contingent upon the successful up listing to NASDA...
MIRAMAR, Fla., May 16, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) is pleased to announce that its Subsidiary, Olaregen Therapeutix has officially launched Excellagen Wound Conforming Matrix. Gene...
MIRAMAR, Fla., May 15, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced that the company has postponed the investor conference call scheduled for May 15, 2019. Joseph Moscato, Pre...
MIRAMAR, Fla., May 02, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) is pleased to announce that their wholly-owned subsidiary NuGenerex Diagnostics LLC, ( www.nugenerexdiangostics.com ) has filled ...
News, Short Squeeze, Breakout and More Instantly...
Generex Biotechnology Company Name:
GNBT Stock Symbol:
OTCMKTS Market:
Generex Biotechnology Website:
MIRAMAR, Fla., July 26, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) subsidiary Olaregen Therapeutix announced in May that the company has executed a Distribution Agreement with Nexgen Medical Sdn Bhd, Inc. (“Nexgen”) to be Ge...
Ii-Key Immunotherapeutic Vaccine Technology Ii-Key-SARS-CoV-2 Vaccine Market Potential & International Contracts Market Potential for AE37 (Ii-Key-HER2) Immunotherapeutic Vaccine for breast, prostate, and bladder cancers MIRAMAR, Fla., June 22, 2021 (GLOBE NEWSWIRE) --...
NuGenHealth Software as a Service (SaaS) platform that enables their clients to monitor the health and wellbeing of their patient population. Westside Medicine & Cardiology, Inc. is a professional corporation that engages medical providers who are duly licensed in Ohio ...